Authors:
Doolittle, ND
Muldoon, LL
Brummett, RE
Tyson, RM
Lacy, C
Bubalo, JS
Kraemer, DF
Heinrich, MC
Henry, JA
Neuwelt, EA
Citation: Nd. Doolittle et al., Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors, CLIN CANC R, 7(3), 2001, pp. 493-500
Authors:
Muldoon, LL
Walker-Rosenfeld, SL
Hale, C
Purcell, SE
Bennett, LC
Neuwelt, EA
Citation: Ll. Muldoon et al., Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants, J PHARM EXP, 296(3), 2001, pp. 797-805
Authors:
Neuwelt, EA
Pagel, MA
Hasler, BP
Deloughery, TG
Muldoon, LL
Citation: Ea. Neuwelt et al., Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administrationof alkylators, with or without glutathione depletion in a rat model, CANCER RES, 61(21), 2001, pp. 7868-7874
Authors:
Muldoon, LL
Pagel, MA
Kroll, RA
Brummett, RE
Doolittle, ND
Zuhowski, EG
Egorin, MJ
Neuwelt, EA
Citation: Ll. Muldoon et al., Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity, CLIN CANC R, 6(1), 2000, pp. 309-315
Authors:
Doolittle, ND
Miner, ME
Hall, WA
Siegal, T
Hanson, EJ
Osztie, E
McAllister, LD
Bubalo, JS
Kraemer, DF
Fortin, D
Nixon, R
Muldoon, LL
Neuwelt, EA
Citation: Nd. Doolittle et al., Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors, CANCER, 88(3), 2000, pp. 637-647
Authors:
Muldoon, LL
Pagel, MA
Kroll, RA
Roman-Goldstein, S
Jones, RS
Neuwelt, EA
Citation: Ll. Muldoon et al., A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery, AM J NEUROR, 20(2), 1999, pp. 217-222